Showing results (1-10 of 74) with videos related to
Sort By:
Pageof 8
Expert Opinion on Drug Discovery|November 12, 2013
High-throughput screening and structure-based approaches to hit discovery: is there a clear winner?Harren Jhoti, Stephen Rees, Roberto SolariDrug Discovery Today|May 2, 2002
Structure-based screening of low-affinity compoundsRobin Carr, Harren JhotiCurrent Opinion in Chemical Biology|June 27, 2003
High-throughput crystallography to enhance drug discoveryAndrew Sharff, Harren JhotiChembiochem : a European Journal of Chemical Biology|February 8, 2005
The discovery of novel protein kinase inhibitors by using fragment-based high-throughput x-ray crystallographyAdrian Gill, Anne Cleasby, Harren JhotiNature Reviews. Drug Discovery|July 18, 2002
High-throughput crystallography for lead discovery in drug designTom L Blundell, Harren Jhoti, Chris AbellCurrent Opinion in Chemical Biology|September 14, 2007
Fragment-based screening using X-ray crystallography and NMR spectroscopyHarren Jhoti, Anne Cleasby, Marcel Verdonk, et al.Biochemical Society Transactions|January 28, 2020
Fragments: where are we now?James Osborne, Stanislava Panova, Magdalini Rapti, et al.Chemical Society Reviews|October 14, 2004
High-throughput protein crystallography and drug discoveryIan Tickle, Andrew Sharff, Mladen Vinkovic, et al.Nature Reviews. Drug Discovery|July 16, 2016
Twenty years on: the impact of fragments on drug discoveryDaniel A Erlanson, Stephen W Fesik, Roderick E Hubbard, et al.Nature|June 13, 2003
Oxidation state of the active-site cysteine in protein tyrosine phosphatase 1BRob L M van Montfort, Miles Congreve, Dominic Tisi, et al.Pageof 8